News Daily News Cardiometabolic Trends Dominate First Round of Drugs Chosen for Medicare Price Negotiations L.A. McKeown January 31, 2025
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for January 2025 Shelley Wood January 31, 2025
News Daily News US Football Fans Are Flooded With Ads for Unhealthy Foods Michael O'Riordan January 30, 2025
News Daily News Early Actions by Trump Administration Sow Uncertainty for CV Research Todd Neale January 30, 2025
Presentation Controversies and Advances 2025 The AI Revolution in Clinical Practice: Present & Future Presenter: Sumeet S. Chugh January 30, 2025
Presentation Controversies and Advances 2025 Management of Hyperaldosteronism: Just Treat Medically to Cast a Wider Net! Presenter: Richard J. Auchus January 30, 2025
Presentation Controversies and Advances 2025 Management of Hyperaldosteronism: Adrenalectomy Has the Best Outcomes! Presenter: Yufei Chen January 30, 2025
Presentation Controversies and Advances 2025 Future Interventions for the Heart & Other Organs: “The Internet of the Human Body” Presenter: Kalyanam Shivkumar January 30, 2025
Presentation Controversies and Advances 2025 Familial Chylomicronemia Syndrome: Emerging Treatment Technologies Presenter: Peter P. Toth January 30, 2025
Presentation Controversies and Advances 2025 Cuffless blood pressure devices: Are they ready for prime time? Presenter: Jennifer L. Cluett January 30, 2025
News Daily News Mental Stress Score May Pinpoint Stable CAD Patients at Risk for CV Events L.A. McKeown January 28, 2025
News Daily News AHA Stats Show CV Health of Americans Remains Dire Michael O'Riordan January 28, 2025
News Daily News Aspirin Use for Primary Prevention Declining in US: NHANES Michael O'Riordan January 24, 2025
News Daily News DRIVE-STEMI Supports Less Restrictive Driving Guidance After Acute MI L.A. McKeown January 23, 2025
News Daily News Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study Michael O'Riordan January 22, 2025
News Daily News European Medicines Agency Investigating GLP-1 Drugs and Eye Disease L.A. McKeown January 21, 2025